Results 261 to 270 of about 29,988 (285)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fecal Microbiota Transplantation in Dogs
Veterinary Clinics of North America: Small Animal Practice, 2021In people, fecal microbiota transplantation is recognized as the best treatment modality for recurrent Clostridioides difficile infection in people, and its value is currently investigated in the treatment of other diseases associated with an abnormal gut microbiome.
Jennifer, Chaitman, Frédéric, Gaschen
openaire +2 more sources
Fecal Microbiota Transplantation
JAMA, 2017Fecal microbiota transplantation (FMT) is the transfer of stool from a healthy donor into the colon of a patient whose disease is a result of an altered microbiome, with the goal of restoring the normal microbiota and thus curing the disease. The most effective and well-studied indication for FMT is recurrent Clostridium difficile infection.
Arjun, Gupta, Sahil, Khanna
openaire +4 more sources
[Fecal microbiota transplantation].
Vnitrni lekarstvi, 2016Fecal microbiota transplantation (FMT) is a therapeutic method, in which the fecal microflora from healthy donors is transmitted to the patient to restore the healthy microbial composition of the gut. In the recent years, there is a growing interest in the therapeutic potential of FMT in various diseases.
Igor, Šturdík +2 more
+10 more sources
Fecal microbiota transplantation
Current Opinion in Gastroenterology, 2014To review the current evidence on fecal microbiota transplantations (FMTs) for recurrent Clostridium difficile infections (CDIs), metabolic syndrome and inflammatory bowel disease.Recently, a randomized trial confirmed the efficacy of this treatment strategy in patients with recurrent CDI. For other disorders, evidence is still limited.
Els, van Nood +3 more
openaire +2 more sources
How to Manipulate the Microbiota: Fecal Microbiota Transplantation
2016Fecal microbiota transplantation (FMT) is a rather straightforward therapy that manipulates the human gastrointestinal (GI) microbiota, by which a healthy donor microbiota is transferred into an existing but disturbed microbial ecosystem. This is a natural process that occurs already at birth; infants are rapidly colonized by a specific microbial ...
Fuentes Enriquez de Salamanca, Susana +1 more
openaire +2 more sources
Ecological principles of fecal microbiota transplantation
Trends in Microbiology, 2023Fecal microbiota transplantation (FMT) is a procedure used to treat diseases related to microbiome imbalances. We discuss how ecological principles can inform the design of FMT clinical trials and contribute to data interpretation. This effort will promote a better understanding of microbiome engraftment and assist the development of clinical protocols.
Francisco Dini-Andreote +1 more
openaire +2 more sources
Fecal microbiota transplantation
Current Opinion in Gastroenterology, 2013Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI ...
Olga C, Aroniadis, Lawrence J, Brandt
openaire +2 more sources
Fecal Microbiota Transplantation as a Cancer Therapeutic
The Cancer Journal, 2023Abstract For decades, cancer research and treatment focused on the cellular level, viewing cancer as a genetic disease of cell transformation. In the era of chemotherapy and radiotherapy, studies from the second half of the 19th century suggesting an association between the microbiota and cancer were almost neglected.
Ronen, Stoff, Yochai, Wolf, Ben, Boursi
openaire +2 more sources
Therapeutic Potential of Fecal Microbiota Transplantation
Gastroenterology, 2013There has been growing interest in the use of fecal microbiota for the treatment of patients with chronic gastrointestinal infections and inflammatory bowel diseases. Lately, there has also been interest in its therapeutic potential for cardiometabolic, autoimmune, and other extraintestinal conditions that were not previously considered to be ...
Smits, L.P. +4 more
openaire +3 more sources

